S. 906 · 118th Congress (2023–2025)
Ending Normal Trade Relations with China Act of 2023
This bill withdraws normal trade relations treatment (i.e., nondiscriminatory treatment) from China.
Further, the bill (1) sets the applicable duty rates on U.S. imports from China as the rates listed in column 2 of the U.S. Harmonized Tariff Schedule, and (2) authorizes the President to further increase the applicable duty rates.
These provisions become effective two years after the bill's enactment.
Show official title
A bill to withdraw normal trade relations treatment from products of the People's Republic of China, and for other purposes.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 906’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Josh Hawley (R-MO)
- Policy area
- Foreign Trade and International Finance
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Finance.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Finance → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
Ending Normal Trade Relations with China Act of 2023
Display title, Short title · Introduced in Senate
A bill to withdraw normal trade relations treatment from products of the People's Republic of China, and for other purposes.
Official title · Introduced in Senate